"Absorbable Implants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Implants constructed of materials designed to be absorbed by the body without producing an immune response. They are usually composed of plastics and are frequently used in orthopedics and orthodontics.
Descriptor ID |
D020341
|
MeSH Number(s) |
E07.695.025
|
Concept/Terms |
Absorbable Implants- Absorbable Implants
- Biodegradable Implants
- Biodegradable Implant
- Implant, Biodegradable
- Implants, Biodegradable
- Bioabsorbable Implants
- Bioabsorbable Implant
- Implant, Bioabsorbable
- Implants, Bioabsorbable
- Implants, Absorbable
- Absorbable Implant
- Implant, Absorbable
|
Below are MeSH descriptors whose meaning is more general than "Absorbable Implants".
Below are MeSH descriptors whose meaning is more specific than "Absorbable Implants".
This graph shows the total number of publications written about "Absorbable Implants" by people in this website by year, and whether "Absorbable Implants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2004 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2013 | 1 | 1 | 2 |
2018 | 3 | 0 | 3 |
2020 | 2 | 1 | 3 |
2022 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Absorbable Implants" by people in Profiles.
-
Engineering Analysis of Non-Braided Polycaprolactone Bioresorbable Flow Diverters for Aneurysms. J Biomech Eng. 2023 11 01; 145(11).
-
Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Less Is Not Always More. JACC Cardiovasc Interv. 2022 06 13; 15(11):1164-1166.
-
Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY. Catheter Cardiovasc Interv. 2021 01 01; 97(1):63-71.
-
Comparison of One-Year Outcomes in Patients >75 Versus =75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry). Am J Cardiol. 2020 07 15; 127:1-8.
-
1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents. JACC Cardiovasc Interv. 2020 04 13; 13(7):820-830.
-
1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration. JACC Cardiovasc Interv. 2018 10 08; 11(19):1969-1978.
-
Reinforced Electrospun Polycaprolactone Nanofibers for Tracheal Repair in an In Vivo Ovine Model. Tissue Eng Part A. 2018 09; 24(17-18):1301-1308.
-
Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions. J Invasive Cardiol. 2018 07; 30(7):251-255.
-
Safety and efficacy of recombinant human bone morphogenetic protein 2 on cranial defect closure in the pediatric population. J Craniofac Surg. 2013 May; 24(3):917-22.
-
Controlled release of metronidazole from composite poly-e-caprolactone/alginate (PCL/alginate) rings for dental implants. Dent Mater. 2013 Jun; 29(6):656-65.